Synthesis and characterization of a diruthenium-ibuprofenato complex comparing its anti-inflammatory activity with that of a copper(II)-ibuprofenato complex.

[1]  W. Farrar,et al.  Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. , 1999, Oncology reports.

[2]  D. Kyriakidis,et al.  Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions. , 1998, Journal of inorganic biochemistry.

[3]  A. Makheja,et al.  Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. , 1998, Anticancer research.

[4]  L. Ghosh,et al.  Product development studies on the tablet formulation of ibuprofen to improve bioavailability. , 1998, Drug Development and Industrial Pharmacy.

[5]  A. Spek,et al.  Dinuclear Paddle-Wheel Copper(II) Carboxylates in the Catalytic Oxidation of Carboxylic Acids. Unusual Polymeric Chains Found in the Single-Crystal X-ray Structures of [Tetrakis(&mgr;-1-phenylcyclopropane-1-carboxylato-O,O')bis(ethanol-O)dicopper(II)] and catena-Poly[[bis(&mgr;-diphenylacetato-O:O') , 1997, Inorganic chemistry.

[6]  A. Abuhijleh.  Synthesis and characterization of copper-ibuprofenate complexes with 2, 2′-bipyridine and 1, 10-phenanthrolines and their hydrolytic activities in phosphate diester cleavage , 1997 .

[7]  F. Cotton,et al.  Preparation and crystal structure of a dimolybdenum(II) complex with the drug ibuprofen , 1996 .

[8]  S. Sen,et al.  1H NMR Analysis of R/S Ibuprofen by the Formation of Diasteriomeric Pairs: Microscale Stereochemistry Experiment for the Undergraduate Organic Laboratory , 1996 .

[9]  A. Abuhijleh.  Mononuclear and binuclear copper(II) complexes of the antiinflammatory drug ibuprofen: synthesis, characterization, and catecholase-mimetic activity. , 1994, Journal of inorganic biochemistry.

[10]  R. Najjar,et al.  Synthesis, characterization, and biological screening of a copper flurbiprofen complex with anti-inflammatory effects. , 1991, Journal of inorganic biochemistry.

[11]  T. Oshiro,et al.  Pharmacological assay of Casearia sylvestris. I: Preventive anti-ulcer activity and toxicity of the leaf crude extract. , 1990, Journal of ethnopharmacology.

[12]  Y. Muto,et al.  Factors affecting the magnetic properties of dimeric copper(II) complexes , 1988 .

[13]  V. Miskowski,et al.  Electronic spectra of Ru2(carboxylate)4+ complexes. Higher energy electronic excited states , 1988 .

[14]  J. Sorenson.  Biology of Copper Complexes , 1987, Experimental Biology and Medicine.

[15]  G. Deacon,et al.  Diagnosis of the nature of carboxylate coordination from the direction of shifts of carbonoxygen stretching frequencies , 1985 .

[16]  J. Telser,et al.  Correction: Reinvestigation of the Electronic and Magnetic Properties of Ruthenium Butyrate Chloride , 1984 .

[17]  L. Oberley,et al.  Copper complexes: a physiological approach to the treatment of ‘inflammatory diseases’ , 1984 .

[18]  M. Melnik.  Mono-, bi-, tetra- and polynuclear copper(II) halogenocarboxylates , 1981 .

[19]  G. O. Carlisle,et al.  Synthesis and magnetic properties of bis[2-(4-isobutylphenyl)propionato]copper(II) , 1981 .

[20]  A. C. Goudie,et al.  The role of copper in preventing gastrointestinal damage by acidic anti‐inflammatory drugs , 1976, The Journal of pharmacy and pharmacology.

[21]  W. Foye,et al.  Synthesis and biological evaluation of tetrakis(acetylsalicylato)‐μ‐dicopper(II) , 1976 .

[22]  W. Geary.  The use of conductivity measurements in organic solvents for the characterisation of coordination compounds , 1971 .